Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Wednesday, November 11, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
FDA Approves Amivantamab-vmjw with Carboplatin and Pemetrexed for NSCLC with EGFR...
Ogkologos
-
September 24, 2024
0
177Lu-PSMA-617 Prolongs rPFS Relative to Androgen Receptor Pathway Inhibitor Change, with...
Ogkologos
-
September 23, 2024
0
Breast Cancer May Spread by Recruiting Nearby Sensory Nerves
Ogkologos
-
September 20, 2024
0
Inhibition of GDF-15 with Ponsegromab Results in Increased Weight Gain and...
Ogkologos
-
September 20, 2024
0
Clinical Trial Results Support Uninterrupted Use of Imatinib for Some Gastrointestinal...
Ogkologos
-
September 19, 2024
0
FDA Approves Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant...
Ogkologos
-
September 19, 2024
0
FDA Approves Neoadjuvant/Adjuvant Durvalumab for Patients with Resectable NSCLC
Ogkologos
-
September 18, 2024
0
Sacituzumab Govitecan Demonstrates a Relatively High ORR with Rapid Responses in...
Ogkologos
-
September 16, 2024
0
Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers
Ogkologos
-
September 14, 2024
0
Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group...
Ogkologos
-
September 13, 2024
0
1
...
69
70
71
...
440
Page 70 of 440
MOST POPULAR
Tyrosine Kinase Inhibitor Prolongs Progression-Free Survival in Rare Neuroendocrine Tumours [ESMO...
September 20, 2021
FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and...
October 7, 2026
FDA Approves Safety Labelling Changes Regarding DPD Deficiency for Fluorouracil Injection...
April 19, 2024
Research with Integrity – integrating training into research culture
January 24, 2023
Load more
HOT NEWS
Cancer Survivor with Strong Family History Was Denied Regular Screening Because...
Stopping the spread: A revolution in how we think about metastasis
Durable Antitumour Activity of Pembrolizumab Plus Lenvatinib in Patients with Previously...
NECTIN4 Amplification Predicts Response to Enfortumab Vedotin and Long-Term Survival in...
Ελληνικά
English (UK)
